Such an assumption is supported by data confirming that MYC suppression could reverse tumorigenesis, which was detected in a variety of tumors such as lymphoma, leukemia, epithelial tumors, and mesenchymal tumors [45,46,47,48]. This evidence concerns the gene MYC and mesenchymal cell neoplasm.